comparemela.com
Home
Live Updates
Child Level Menu Hover - Breaking News
Pages:
3
4
5
6
7
8
9
Latest Breaking News On - Child level menu hover - Page 2 : comparemela.com
SRI, Amylyx Pharmaceuticals partner to identify ALS drug candidates
SRI and Amylyx have joined forces to develop new drug candidates to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Menu hover
Subchild level menu hover
Child level menu hover
End third level
Bend article
End timeline
Mogrify, Astellas Pharma partner for sensorineural hearing loss treatment
Mogrify has collaborated with Astellas Pharma to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss.
Menu hover
Subchild level menu hover
Child level menu hover
End third level
Bend article
End timeline
ViGeneron signs collaboration agreement with Regeneron Pharmaceuticals
ViGeneron, a Germany-based gene therapy company, has entered a target-specific strategic collaboration and option agreement with Regeneron Pharmaceuticals.
Regeneron pharmaceuticals
Menu hover
Subchild level menu hover
Child level menu hover
End third level
Bend article
End timeline
Bristol Myers Squibb gets FDA approval for metastatic melanoma therapy
Bristol Myers Squibb has obtained approval from the US FDA for Opdualag to treat unresectable or metastatic melanoma patients.
Bristol myers squibb opdualag
Samit hirawat
Drug administration
Bristol myers squibb
Bristol myers squibb company
Myers squibb
Menu hover
Subchild level menu hover
Child level menu hover
Sanofi, Blackstone partner to advance multiple myeloma treatment
Sanofi has announced a collaboration with investment management firm Blackstone to advance an innovative treatment for multiple myeloma.
Menu hover
Subchild level menu hover
Child level menu hover
End third level
vimarsana © 2020. All Rights Reserved.